A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice

Nucleic Acids Research

Volumn 44, Issue 13, 2016, Pages 6423-6433

  Qin, Wangshu ^a   Li, Xinzhi ^a   Xie, Liwei ^b,e   Li, Sha ^a   Liu, Jianan ^a   Jia, Linna ^a   Dong, Xue ^a   Ren, Xiaomeng ^a   Xiao, Junjie ^c   Yang, Changqing ^d   Zhou, Yifa ^a   Chen, Zheng ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c SHANGHAI UNIVERSITY   (China)

^d TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; CHOLESTEROL; COMPLEMENTARY RNA; ELAV LIKE PROTEIN 1; LONG UNTRANSLATED RNA; MESSENGER RNA; TRIACYLGLYCEROL; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; ELAVL1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOA4 AS GENE; APOA4 GENE; ARTICLE; CONTROLLED STUDY; EMBRYO; FATTY LIVER; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN STABILITY; RNA ANALYSIS; ANIMAL; BIOSYNTHESIS; BLOOD; GENETICS; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; APOLIPOPROTEINS A; CHOLESTEROL; ELAV-LIKE PROTEIN 1; FATTY LIVER; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER; MICE; RNA, LONG NONCODING; TRIGLYCERIDES;

EID: 84982797835     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw341     Document Type: Article

References (43)

1. Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D.G. et al. (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome research, 22, 1775-1789.
2. Katayama, S., Tomaru, Y., Kasukawa, T., Waki, K., Nakanishi, M., Nakamura, M., Nishida, H., Yap, C.C., Suzuki, M., Kawai, J. et al. (2005) Antisense transcription in the mammalian transcriptome. Science, 309, 1564-1566.
3. Khorkova, O., Myers, A.J., Hsiao, J. and Wahlestedt, C. (2014) Natural antisense transcripts. Hum. Mol. Genet., 23, R54-R63.
4. Tseng, Y.Y., Moriarity, B.S., Gong, W., Akiyama, R., Tiwari, A., Kawakami, H., Ronning, P., Reuland, B., Guenther, K., Beadnell, T.C. et al. (2014) PVT1 dependence in cancer with MYC copy-number increase. Nature, 512, 82-86.
5. Mirza, A.H., Kaur, S., Brorsson, C.A. and Pociot, F. (2014) Effects of GWAS-Associated Genetic Variants on lncRNAs within IBD and T1D Candidate Loci. PLoS ONE, 9, e105723.
6. Reddy, M.A., Chen, Z., Park, J.T., Wang, M., Lanting, L., Zhang, Q., Bhatt, K., Leung, A., Wu, X., Putta, S. et al. (2014) Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. Diabetes, 63, 4249-4261.
7. Wang, F., Kohan, A.B., Lo, C.M., Liu, M., Howles, P. and Tso, P. (2015) Apolipoprotein A-IV: a protein intimately involved in metabolism. J. Lipid Res., 56, 1403-1418.
8. Duverger, N., Tremp, G., Caillaud, J.M., Emmanuel, F., Castro, G., Fruchart, J.C., Steinmetz, A. and Denefle, P. (1996) Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science, 273, 966-968.
9. Recalde, D., Ostos, M.A., Badell, E., Garcia-Otin, A.L., Pidoux, J., Castro, G., Zakin, M.M. and Scott-Algara, D. (2004) Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol., 24, 756-761.
10. Khovidhunkit, W., Duchateau, P.N., Medzihradszky, K.F., Moser, A.H., Naya-Vigne, J., Shigenaga, J.K., Kane, J.P., Grunfeld, C. and Feingold, K.R. (2004) Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis, 176, 37-44.
11. Boerwinkle, E., Visvikis, S. and Chan, L. (1990) Two polymorphisms for amino acid substitutions in the APOA4 gene. Nucleic Acids Res., 18, 4966.
12. Dallongeville, J., Delcroix, A.G., Wagner, A., Ducimetiere, P., Ruidavets, J.B., Arveiler, D., Bingham, A., Ferrieres, J., Amouyel, P. and Meirhaeghe, A. (2005) The APOA4 Thr347->Ser347 polymorphism is not a major risk factor of obesity. Obes. Res., 13, 2132-2138.
13. Gomez, P., Perez-Martinez, P., Marin, C., Camargo, A., Yubero-Serrano, E.M., Garcia-Rios, A., Rodriguez, F., Delgado-Lista, J., Perez-Jimenez, F. and Lopez-Miranda, J. (2010) APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults. J. Nutr., 140, 773-778.
14. Guclu-Geyik, F., Onat, A., Coban, N., Komurcu-Bayrak, E., Sansoy, V., Can, G. and Erginel-Unaltuna, N. (2012) Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women. Mol. Biol. Rep., 39, 10907-10914.
15. Herron, K.L., Lofgren, I.E., Adiconis, X., Ordovas, J.M. and Fernandez, M.L. (2006) Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis, 184, 113-120.
16. VerHague, M.A., Cheng, D., Weinberg, R.B. and Shelness, G.S. (2013) Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler. Thromb. Vasc. Biol., 33, 2501-2508.
17. Wang, F., Kohan, A.B., Kindel, T.L., Corbin, K.L., Nunemaker, C.S., Obici, S., Woods, S.C., Davidson, W.S. and Tso, P. (2012) Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion. Proc. Natl. Acad. Sci. U.S.A., 109, 9641-9646.
18. Li, X., Xu, M., Wang, F., Kohan, A.B., Haas, M.K., Yang, Q., Lou, D., Obici, S., Davidson, W.S. and Tso, P. (2014) Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1. J. Biol. Chem., 289, 2396-2404.
19. Sleddering, M.A., Markvoort, A.J., Dharuri, H.K., Jeyakar, S., Snel, M., Juhasz, P., Lynch, M., Hines, W., Li, X., Jazet, I.M. et al. (2014) Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers. PLoS ONE, 9, e112835.
20. Sanecka, A., Ansems, M., van Hout-Kuijer, M.A., Looman, M.W., Prosser, A.C., Welten, S., Gilissen, C., Sama, I.E., Huynen, M.A., Veltman, J.A. et al. (2012) Analysis of genes regulated by the transcription factor LUMAN identifies ApoA4 as a target gene in dendritic cells. Mol. Immunol., 50, 66-73.
21. Xu, X., Park, J.-G., So, J.-S., Hur, K.Y. and Lee, A.-H. (2014) Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH. J. Lipid Res., 55, 850-859.
22. Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel, H., Salzberg, S.L., Rinn, J.L. and Pachter, L. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc., 7, 562-578.
23. Chen, Z., Shen, H., Sun, C., Yin, L., Tang, F., Zheng, P., Liu, Y., Brink, R. and Rui, L. (2015) Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. Am. J. Physiol. Endocrinol.Metab., 308, E460-E469.
24. Chen, Z., Sheng, L., Shen, H., Zhao, Y., Wang, S., Brink, R. and Rui, L. (2012) Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes, 61, 566-573.
25. Chen, Z., Canet, M.J., Sheng, L., Jiang, L., Xiong, Y., Yin, L. and Rui, L. (2015) Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity. Mol. Metab., 4, 951-960.
26. Maggio, I., Holkers, M., Liu, J., Janssen, J.M., Chen, X. and Gonçalves, M.A.F.V. (2014) Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Sci. Rep., 4, 5105.
27. Zhou, Y., Zhu, S., Cai, C., Yuan, P., Li, C., Huang, Y. and Wei, W. (2014) High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature, 509, 487-491.
28. Zhang, F., Xu, X., Zhang, Y., Zhou, B., He, Z. and Zhai, Q. (2013) Gene expression profile analysis of type 2 diabetic mouse liver. PLoS ONE, 8, e57766.
29. Mudge, J.M. and Harrow, J. (2015) Creating reference gene annotation for the mouse C57BL6/J genome assembly. Mamm. Genome, 26, 366-378.
30. Kohan, A.B., Wang, F., Lo, C.-M., Liu, M. and Tso, P. (2015) ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety. Am. J. Physiol. Gastrointest. Liver Physiol., 308, G472-G481.
31. Halley, P., Kadakkuzha, B.M., Faghihi, M.A., Magistri, M., Zeier, Z., Khorkova, O., Coito, C., Hsiao, J., Lawrence, M. and Wahlestedt, C. (2014) Regulation of the apolipoprotein gene cluster by a long noncoding RNA. Cell Rep., 6, 222-230.
32. Cao, C., Sun, J., Zhang, D., Guo, X., Xie, L., Li, X., Wu, D. and Liu, L. (2015) The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of beta-catenin in HCC cells. Gastroenterology, 148, 415-426.
33. Bartolome, N., Aspichueta, P., Martinez, M.J., Vazquez-Chantada, M., Martinez-Chantar, M.L., Ochoa, B. and Chico, Y. (2012) Biphasic adaptative responses in VLDL metabolism and lipoprotein homeostasis during Gram-negative endotoxemia. Innate Immun., 18, 89-99.
34. Leppek, K. and Stoecklin, G. (2014) An optimized streptavidin-binding RNA aptamer for purification of ribonucleoprotein complexes identifies novel ARE-binding proteins. Nucleic Acids Res., 42, e13.
35. Kohan, A.B., Wang, F., Li, X., Bradshaw, S., Yang, Q., Caldwell, J.L., Bullock, T.M. and Tso, P. (2012) Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function. Am. J. Physiol. Gastrointest. Liver Physiol., 302, G628-G636.
36. Fujimoto, K., Fukagawa, K., Sakata, T. and Tso, P. (1993) Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest., 91, 1830-1833.
37. Shen, L., Pearson, K.J., Xiong, Y., Lo, C.M., Tso, P., Woods, S.C., Davidson, W.S. and Liu, M. (2008) Characterization of apolipoprotein A-IV in brain areas involved in energy homeostasis. Physiol. Behav., 95, 161-167.
38. Weinstock, P.H., Bisgaier, C.L., Hayek, T., Aalto-Setala, K., Sehayek, E., Wu, L., Sheiffele, P., Merkel, M., Essenburg, A.D. and Breslow, J.L. (1997) Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice. J. Lipid Res., 38, 1782-1794.
39. Carrier, J.C., Deblois, G., Champigny, C., Levy, E. and Giguère, V. (2004) Estrogen-related receptor α (ERRα) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J. Biol. Chem., 279, 52052-52058.
40. Nagasawa, M., Hara, T., Kashino, A., Akasaka, Y., Ide, T. and Murakami, K. (2009) Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene. Biochem. Pharmacol., 78, 523-530.
41. Chen, Z. (2016) Progress and prospects of long noncoding RNAs in lipid homeostasis. Mol. Metab., 5, 164-170.
42. Houseley, J. and Tollervey, D. (2009) The many pathways of RNA degradation. Cell, 136, 763-776.
43. Hoque, M., Ji, Z., Zheng, D., Luo, W., Li, W., You, B., Park, J.Y., Yehia, G. and Tian, B. (2013) Analysis of alternative cleavage and polyadenylation by 3′ region extraction and deep sequencing. Nat. Methods, 10, 133-139.